Trials / Unknown
UnknownNCT05648370
Liquid Biopsy in Advanced Oligometastatic NSCLC Receiving Surgery
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 60 (estimated)
- Sponsor
- Guangdong Provincial People's Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A prospective, observational study that assesses the clinical feasibility of ctDNA-based liquid biopsy in patients with oligometastatic NSCLC receiving surgery.
Detailed description
60 eligible patients will be enrolled. Dynamic blood samples before and after surgery and tissue samples will be obtained for exploratory analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | ctDNA testing and whole exome sequencing | Blood samples will be obtained for ctDNA testing and tumor tissue for whole exome sequencing. |
Timeline
- Start date
- 2022-07-01
- Primary completion
- 2024-06-30
- Completion
- 2025-06-30
- First posted
- 2022-12-13
- Last updated
- 2022-12-13
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT05648370. Inclusion in this directory is not an endorsement.